Insights

Rapid Diagnostic Innovation Credo Diagnostics Biomedical's flagship VitaPCR platform provides rapid, cost-effective molecular diagnostics for infectious diseases, including COVID-19, influenza, and RSV. This positions the company well to expand into healthcare settings requiring swift pathogen detection, presenting sales opportunities with hospitals, clinics, and point-of-care testing providers.

Market Growth Potential With an estimated revenue between 1M and 10M and a focus on human and animal health diagnostics, Credo is positioned in a growing industry segment. Collaborations or integrations with veterinary clinics and animal health companies could open avenues for diversification and increased sales.

Technology Leadership Credo's emphasis on molecular diagnostics and user-friendly POC solutions offers an advantage in markets seeking innovative healthcare testing devices. Partnering with institutions aiming to adopt cutting-edge diagnostic technologies could boost sales and market share.

Global Expansion Opportunities Operating from Singapore and utilizing a multilingual website with tools like Weglot, Credo shows readiness for expansion into international markets. Targeting global health agencies, distributors, and multinational medical suppliers can facilitate broader sales reach.

Industry Collaboration Potential Credo's focus on cost-effective and simplified testing methods makes them an attractive partner for pharmaceutical and biotechnology companies seeking reliable diagnostic tools. Building alliances can accelerate sales efforts and foster joint development projects in infectious disease detection.

Similar companies to Credo Diagnostics Biomedical

Credo Diagnostics Biomedical Tech Stack

Credo Diagnostics Biomedical uses 8 technology products and services including 33Across, WordPress, Shopify, and more. Explore Credo Diagnostics Biomedical's tech stack below.

33Across
Advertising
WordPress
Content Management System
Shopify
E-commerce
Microsoft 365
Email
Font Awesome
Font Scripts
imagesLoaded
Javascript Libraries
reCAPTCHA
Security
Weglot
Translation

Media & News

Credo Diagnostics Biomedical Pte. Ltd launched VitaPCR TM on Jan 1st '19.
Founded in 2011, Credo Diagnostics launched the VitaPCR TM in 2019, a revolutionary molecular biology platform capable of detecting infectious pathogens (including the SARS-CoV-2 responsible for Covid-19, influenza and RSV viruses) by Polymerase Chain Reaction (PCR) methodology in only 20 minutes.
Jan 13, 2023 | www.marketscreener.com

Credo Diagnostics Biomedical's Email Address Formats

Credo Diagnostics Biomedical uses at least 1 format(s):

Credo Diagnostics Biomedical Email Formats	Example	Percentage
First.Last@credodxbiomed.com	John.Doe@credodxbiomed.com	42%
FMiddleLast@credodxbiomed.com	JMichaelDoe@credodxbiomed.com	8%
First.Last@credodxbiomed.com	John.Doe@credodxbiomed.com	42%
FMiddleLast@credodxbiomed.com	JMichaelDoe@credodxbiomed.com	8%

Frequently Asked Questions

Where is Credo Diagnostics Biomedical's headquarters located?

Credo Diagnostics Biomedical's main headquarters is located at 491B River Valley Road, #06-01 Valley Point Singapore, 248373, SG. The company has employees across 2 continents, including AsiaEurope.

What is Credo Diagnostics Biomedical's official website and social media links?

Credo Diagnostics Biomedical's official website is credodxbiomed.com and has social profiles on LinkedIn.

What is Credo Diagnostics Biomedical's NAICS code?

Credo Diagnostics Biomedical's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Credo Diagnostics Biomedical have currently?

As of October 2025, Credo Diagnostics Biomedical has approximately 201 employees across 2 continents, including AsiaEurope. Key team members include Chairman: W. J. W.Head, Chairman’s Office / Vice President: T. T.Vp: S. K.. Explore Credo Diagnostics Biomedical's employee directory with LeadIQ.

What industry does Credo Diagnostics Biomedical belong to?

Credo Diagnostics Biomedical operates in the Medical Equipment Manufacturing industry.

What technology does Credo Diagnostics Biomedical use?

Credo Diagnostics Biomedical's tech stack includes 33AcrossWordPressShopifyMicrosoft 365Font AwesomeimagesLoadedreCAPTCHAWeglot.

What is Credo Diagnostics Biomedical's email format?

Credo Diagnostics Biomedical's email format typically follows the pattern of First.Last@credodxbiomed.com. Find more Credo Diagnostics Biomedical email formats with LeadIQ.

When was Credo Diagnostics Biomedical founded?

Credo Diagnostics Biomedical was founded in 2011.

Credo Diagnostics Biomedical

Medical Equipment ManufacturingSingapore201-500 Employees

Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases and animal health.

At Credo Diagnostics Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. 

By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world. 

For any inquiries, please contact us at: service@credodxbiomed.com

Company Overview

Headquarters: 491B River Valley Road, #06-01 Valley Point Singapore, 248373, SG
Website: credodxbiomed.com
NAICS Code: 3391 - Medical Equipment and Supplies Manufacturing
Founded: 2011
Employees: 201-500